Early presymptomatic cholinergic dysfunction in a murine model of amyotrophic lateral sclerosis

被引:60
|
作者
Casas, Caty [1 ,2 ]
Herrando-Grabulosa, Mireia [1 ,2 ]
Manzano, Raquel [3 ]
Mancuso, Renzo [1 ,2 ]
Osta, Rosario [3 ]
Navarro, Xavier [1 ,2 ]
机构
[1] Univ Autonoma Barcelona, Grp Neuroplast & Regenerat, Dept Cell Biol Physiol & Immunol, Inst Neurosci, Bellaterra, Spain
[2] Ctr Invest Biomed Red Enfermedades Enfermedades, Bellaterra, Spain
[3] Univ Zaragoza, Aragon Inst Hlth Sci, Lab Genet Biochem LAGENBIO I3A, Zaragoza, Spain
来源
BRAIN AND BEHAVIOR | 2013年 / 3卷 / 02期
关键词
Amyotrophic lateral sclerosis; ChAT; MHC-I; motoneuron; presynaptic boutons; Tdp-43; MOTOR-NEURON DISEASE; TRANSGENIC MOUSE MODEL; ALPHA-MOTONEURONS; AXONAL-TRANSPORT; ANTERIOR HORN; C-TERMINALS; SPINAL-CORD; ACETYLTRANSFERASE; MICE; RAT;
D O I
10.1002/brb3.104
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Sporadic and familiar amyotrophic lateral sclerosis (ALS) cases presented lower cholinergic activity than in healthy individuals in their still preserved spinal motoneurons (MNs) suggesting that cholinergic reduction might occur before MN death. To unravel how and when cholinergic function is compromised, we have analyzed the spatiotemporal expression of choline acetyltransferase (ChAT) from early presymptomatic stages of the SOD1(G93A) ALS mouse model by confocal immunohistochemistry. The analysis showed an early reduction in ChAT content in soma and presynaptic boutons apposed onto MNs (to 76%) as well as in cholinergic interneurons in the lumbar spinal cord of the 30-day-old SOD1(G93A) mice. Cholinergic synaptic stripping occurred simultaneously to the presence of abundant surrounding major histocompatibility complex II (MHC-II)-positive microglia and the accumulation of nuclear Tdp-43 and the appearance of mild oxidative stress within MNs. Besides, there was a loss of neuronal MHC-I expression, which is necessary for balanced synaptic stripping after axotomy. These events occurred before the selective raise of markers of denervation such as ATF3. By the same time, alterations in postsynaptic cholinergic- related structures were also revealed with a loss of the presence of sigma-1 receptor, a Ca2+ buffering chaperone in the postsynaptic cisternae. By 2 months of age, ChAT seemed to accumulate in the soma of MNs, and thus efferences toward Renshaw interneurons were drastically diminished. In conclusion, cholinergic dysfunction in the local circuitry of the spinal cord may be one of the earliest events in ALS etiopathogenesis.
引用
收藏
页码:145 / 158
页数:14
相关论文
共 50 条
  • [1] Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis
    Verma, Sagar
    Khurana, Shiffali
    Vats, Abhishek
    Sahu, Bandana
    Ganguly, Nirmal Kumar
    Chakraborti, Pradip
    Gourie-Devi, Mandaville
    Taneja, Vibha
    MOLECULAR NEUROBIOLOGY, 2022, 59 (03) : 1502 - 1527
  • [2] Mitochondrial dysfunction in amyotrophic lateral sclerosis
    Shi, Ping
    Gal, Jozsef
    Kwinter, David M.
    Liu, Xiaoyan
    Zhu, Haining
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2010, 1802 (01): : 45 - 51
  • [3] Early dysfunction of spinal cord interneurons in a mouse model of amyotrophic lateral sclerosis
    Soares-Neto, Rubens
    Calixtro, Joao
    Ribeiro, Felipe C.
    JOURNAL OF PHYSIOLOGY-LONDON, 2023, 601 (06): : 1057 - 1058
  • [4] Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis
    Philips, Thomas
    Bento-Abreu, Andre
    Nonneman, Annelies
    Haeck, Wanda
    Staats, Kim
    Geelen, Veerle
    Hersmus, Nicole
    Kusters, Benno
    Van den Bosch, Ludo
    Van Damme, Philip
    Richardson, William D.
    Robberecht, Wim
    BRAIN, 2013, 136 : 471 - 482
  • [5] The Impact of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis
    Zhao, Jiantao
    Wang, Xuemei
    Huo, Zijun
    Chen, Yanchun
    Liu, Jinmeng
    Zhao, Zhenhan
    Meng, Fandi
    Su, Qi
    Bao, Weiwei
    Zhang, Lingyun
    Wen, Shuang
    Wang, Xin
    Liu, Huancai
    Zhou, Shuanhu
    CELLS, 2022, 11 (13)
  • [6] Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?
    Muyderman, H.
    Chen, T.
    BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (08) : 2191 - 2205
  • [7] Therapeutic effects of clenbuterol in a murine model of amyotrophic lateral sclerosis
    Teng, YD
    Choi, H
    Huang, WZ
    Onario, RC
    Frontera, WR
    Snyder, EY
    Sabharwal, S
    NEUROSCIENCE LETTERS, 2006, 397 (1-2) : 155 - 158
  • [8] Increased phospho-adducin immunoreactivity in a murine model of amyotrophic lateral sclerosis
    Shan, X
    Hu, JH
    Cayabyab, FS
    Krieger, C
    NEUROSCIENCE, 2005, 134 (03) : 833 - 846
  • [9] Amyotrophic Lateral Sclerosis and Autophagy: Dysfunction and Therapeutic Targeting
    Amin, Azin
    Perera, Nirma D.
    Beart, Philip M.
    Turner, Bradley J.
    Shabanpoor, Fazel
    CELLS, 2020, 9 (11) : 1 - 30
  • [10] Amyotrophic Lateral Sclerosis Model
    Azuma, Yumiko
    Mizuta, Ikuko
    Tokuda, Takahiko
    Mizuno, Toshiki
    DROSOPHILA MODELS FOR HUMAN DISEASES, 2018, 1076 : 79 - 95